/Companies

Lyora Therapeutics

Belmont, US · Founded 2024 · Delaware corporation

Find your way into Lyora Therapeutics

Sign up to see every warm intro you have to Lyora Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Lyora Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Founders & leadership

LV
Luc Vandenberghe, PhDNamed on SEC filing

Board

EP
Eric Pierce, MD, PhDBoard director

Funding

SEC filings, press & company announcements

$525K disclosed across 1 of 2 rounds · 2025–2026

  • Undisclosed amountSeedJul 2026 · 3 sources
    Source ↗
▶$525KraisedMar 2025 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Luc Vandenberghe, PhDExecutive Officer, Director
  • Eric Pierce, MD, PhDDirector
Offering amount
$2M
Amount sold
$525K
First sale
Feb 2025
Incorporated
Corporation, Delaware, 2024
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Lyora Therapeutics raised?
Lyora Therapeutics has disclosed $525K raised across 1 of its 2 known rounds.
Where is Lyora Therapeutics headquartered?
Lyora Therapeutics is headquartered in Belmont, US.